These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 10861058)

  • 1. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.
    Diamond AS; Gill RG
    J Immunol; 2000 Jul; 165(1):247-55. PubMed ID: 10861058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles.
    Sleater M; Diamond AS; Gill RG
    Am J Transplant; 2007 Aug; 7(8):1927-33. PubMed ID: 17617855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
    Zhan Y; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Impact of T-bet and IFNγ on Pancreatic Islet Allograft Rejection.
    Besançon A; Demir Z; Goncalves T; Valette F; Panafieu E; Chatenoud L; You S
    Transplantation; 2018 Sep; 102(9):1496-1504. PubMed ID: 29757902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
    Li XC; Roy-Chaudhury P; Hancock WW; Manfro R; Zand MS; Li Y; Zheng XX; Nickerson PW; Steiger J; Malek TR; Strom TB
    J Immunol; 1998 Jul; 161(2):890-6. PubMed ID: 9670967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells.
    Feng Y; Wang D; Yuan R; Parker CM; Farber DL; Hadley GA
    J Exp Med; 2002 Oct; 196(7):877-86. PubMed ID: 12370250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease.
    Ramirez-Montagut T; Chow A; Kochman AA; Smith OM; Suh D; Sindhi H; Lu S; Borsotti C; Grubin J; Patel N; Terwey TH; Kim TD; Heller G; Murphy GF; Liu C; Alpdogan O; van den Brink MR
    J Immunol; 2007 Aug; 179(3):1669-80. PubMed ID: 17641033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
    Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
    J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.
    Coley SM; Ford ML; Hanna SC; Wagener ME; Kirk AD; Larsen CP
    J Immunol; 2009 Jan; 182(1):225-33. PubMed ID: 19109153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor IFN-gamma receptors are critical for acute CD4(+) T cell-mediated cardiac allograft rejection.
    Wiseman AC; Pietra BA; Kelly BP; Rayat GR; Rizeq M; Gill RG
    J Immunol; 2001 Nov; 167(9):5457-63. PubMed ID: 11673565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
    Roth E; Pircher H
    J Immunol; 2004 Feb; 172(3):1588-94. PubMed ID: 14734739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet rejection in perforin-deficient mice: the role of perforin and Fas.
    Ahmed KR; Guo TB; Gaal KK
    Transplantation; 1997 Apr; 63(7):951-7. PubMed ID: 9112346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.
    Simeonovic CJ; Brown DJ; Townsend MJ; Wilson JD
    Cell Transplant; 1996; 5(5):525-41. PubMed ID: 8889212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective depletion of alloreactive T cells leads to long-term islet allograft survival across a major histocompatibility complex mismatch in diabetic mice.
    Hu M; Wu J; Zhang GY; Wang YM; Watson D; Yi S; Hawthorne WJ; O'Connell PJ; Alexander SI
    Cell Transplant; 2013; 22(10):1929-41. PubMed ID: 23107388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
    Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
    Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired recall of CD8 memory T cells in immunologically privileged tissue.
    Dai Z; Nasr IW; Reel M; Deng S; Diggs L; Larsen CP; Rothstein DM; Lakkis FG
    J Immunol; 2005 Feb; 174(3):1165-70. PubMed ID: 15661869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
    Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.